Mucosal immunology · 2026
Intestinal helminths skew dendritic cell development to counter the anti-helminth immune response.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Andrusaite Anna T, White Ruby F, Heawood Anna L L, Ridgewell Olivia, Lints Daisy E, Frede Annika, Ahlback Anna, Wasowska Natalia L, Webster Holly C, Cunningham Kyle T, Yamaguchi Hiroki, Al-Khalidi Sarwah, Peel Molly, Farthing Andrew, Woolcock Kieran P, Smith Annabelle N, Roberts Edward, MacDonald Andrew S, Mowat Allan Mcl, Maizels Rick M, Perona-Wright Georgia, Milling Simon W F
Аннотация
Intestinal dendritic cells (DC) orchestrate the adaptive immune response that balances protection against pathogens and tolerance towards harmless antigens. Yet, it remains largely unknown what molecular mechanisms underly this functional duality. Heligmosomoides polygyrus bakeri (Hpb) is a naturally occurring parasite in mice characterised by unique immune-evasion strategies that counter host protective immunity. Here, we utilised this unique infection environment to study mechanisms by which DC maintain the immune balance. In-depth characterisation of intestinal DC during Hpb infection revealed the emergence of distinct populations of DC that drive protective Th2 responses, versus others with immunoregulatory properties. We also identified that the skewing of intestinal DC towards immunoregulatory functions was due to TGFβ signalling via endogenous sources and by Hpb-produced TGFβ-mimic molecules. Thus, our results present a mechanistic explanation for Hpb's ability to modulate the adaptive immune system. Furthermore, these data offer an example of how heterogeneity within the DC compartment can determine the simultaneous generation of both pro- and anti-inflammatory immune responses.